Sin Don D
Center for Heart Lung Innovation, St. Paul's Hospital and Division of Respiratory Medicine, Department of Medicine, University of British Columbia Vancouver, Vancouver, BC, Canada.
Tuberc Respir Dis (Seoul). 2023 Apr;86(2):71-81. doi: 10.4046/trd.2023.0005. Epub 2023 Mar 28.
Chronic obstructive pulmonary disease (COPD) affects close to 400 million people worldwide. COPD is characterized by significant airflow limitation on spirometry. Most patients with COPD are diagnosed in their fifth or sixth decades of life. However, the disease begins much earlier. By the time airflow limitation is detected on spirometry, patients with COPD have lost close to 50% of their small airways. Thus, identification of patients with early COPD, defined as persons with preserved spirometry, who demonstrate pathologic or functional hallmarks of COPD, is essential for disease modification and ultimately disease elimination. This paper provides an up-to-date overview of the current case definition of early COPD, its importance, the novel technologies required for its detection in young adults and future directions in therapeutics for treatment.
慢性阻塞性肺疾病(COPD)在全球影响着近4亿人。COPD的特征是肺量计检查显示气流严重受限。大多数COPD患者在五六十岁时被诊断出来。然而,这种疾病在更早的时候就开始了。在肺量计检查发现气流受限时,COPD患者已经失去了近50%的小气道。因此,识别早期COPD患者(定义为肺量计检查正常但具有COPD病理或功能特征的人)对于改变疾病进程并最终消除疾病至关重要。本文提供了早期COPD当前病例定义的最新概述、其重要性、在年轻人中检测所需的新技术以及治疗的未来方向。